SUMMARY Following minor surgery performed under topical application of oxybuprocaine (Dorsacaine, Novesin) two patients suffered from fibrinous iritis and moderate corneal swelling. We believe that this represents a toxic reaction caused by an inadvertent entry of this drug into the anterior chamber during the procedure.
R HADDAD From the Second Eye Clinic, University of Vienna, Austria SUMMARY Following minor surgery performed under topical application of oxybuprocaine (Dorsacaine, Novesin) two patients suffered from fibrinous iritis and moderate corneal swelling. We believe that this represents a toxic reaction caused by an inadvertent entry of this drug into the anterior chamber during the procedure.
Oxybuprocaine or benoxinate (Dorsacaine, Novesin) is a topical local anaesthetic which is widely used in diagnostic and surgical procedures in the eye. It is considered to be well tolerated, with only minimal side effects, mainly ocular discomfort (stinging) and punctate corneal epithelial damage.'-3 We report on two patients who developed fibrinous iritis and moderate corneal swelling which we attribute to the instillation of oxybuprocaine during surgery. This side effect of the drug has not been reported elsewhere. CASE 
1
A 61-year-old man underwent an uneventful intracapsular cataract extraction with implantation of an anterior chamber lens (Kelman-Multiflex) in his right eye. On the fourth postoperative day a slight dehiscence of the limbal wound accompanied by hypotony was noted. The anterior chamber was deep, with a minimal cellular flare. Firm patching of the eye over two days was ineffectual and the wound was resutured. Under topical 0-4% oxybuprocaine (Novesin) the fornix-based conjunctival flap was lifted and three loose comeoscleral 10-0 nylon sutures were replaced. Oxybuprocaine had to be instilled several times during the operation, so that direct contact of the drug with the iris was unavoidable. No other drug was administered during the procedure, and the anterior chamber was allowed to reform spontaneously. The conjunctival flap was then fixed with one 8-0 Vicryl suture, an antibioticcorticosteroid ointment was applied, and the eye was patched. Some hours later the patient complained of pain in his eye and forehead, which could be relieved by analgesics.
Next morning examination of the eye disclosed and vision was reduced to hand movements. Therapy consisted of acetylprednisolone (1% solution applied topically every hour) and maximal mydriasis. The fibrinous exudate resolved gradually within one week (Figs. 1A, B) , and vision was ultimately restored.
Discussion
Oxybuprocaine is an effective, well tolerated surface anaesthetic which has been widely used in ophthalmology for about 30 years. Whereas an initial stinging sensation and corneal epithelial changes are probably the only side effects known to be caused by a 0*4% solution,' 2 nothing is known about probable toxic effects of this drug if it inadvertently enters the anterior chamber. Injections of local anaesthetics into the anterior chambers of animals are usually damaging, particularly to the corneal endothelium.4 5 In one patient an accidental injection of amethocaine into the anterior chamber caused severe injury, ending with bullous keratopathy, permanently dilated pupil, and focal iris atrophy. In the present two cases 0-4% and 1 0% solutions of oxybuprocaine were applied to repair minor corneoscleral wound leaks, and no other drug was administered. However, this drug appears to have inadvertently entered the anterior chamber while being instilled during the operation. Shortly after the procedure, both patients presented with similar changes, mainly corneal clouding and fibrinous iritis.
For several reasons we attribute this inflammatory condition to the local anaesthetic: (1) During the entire procedure, no other drug was used which might have elicited such a reaction. (2) Generally, preoperative application of 0.4% oxybuprocaine is adequate to allow the repair of slight wound leaks without further complications. In these two cases, however, additional oxybuprocaine had to be given during the procedure, so that some entered the anterior chamber. (3) The severity of the inflammatory response correlated well with the concentration of the drug instilled-that is, the 1.0% concentration caused a much severer reaction than did a lower concentration.
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